166 related articles for article (PubMed ID: 19563658)
1. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.
Longatto-Filho A; Pinheiro C; Martinho O; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Baltazar F; Reis RM
BMC Cancer; 2009 Jun; 9():212. PubMed ID: 19563658
[TBL] [Abstract][Full Text] [Related]
2. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
[TBL] [Abstract][Full Text] [Related]
3. EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.
Iida K; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Yeasmin S; Otsuki Y; Kobayashi H; Nakayama S; Miyazaki K
Br J Cancer; 2011 Jul; 105(3):420-7. PubMed ID: 21730982
[TBL] [Abstract][Full Text] [Related]
4. Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
Swick BL; Srikantha R; Messingham KN
J Cutan Pathol; 2013 Jul; 40(7):623-30. PubMed ID: 23621836
[TBL] [Abstract][Full Text] [Related]
5. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C
PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986
[TBL] [Abstract][Full Text] [Related]
6. Mutations and protein expression of KIT and PDGFRA genes in ipsilateral testicular seminomas: an immunohistochemical and molecular genetic study.
Terada T
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):450-3. PubMed ID: 21403518
[TBL] [Abstract][Full Text] [Related]
7. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
[TBL] [Abstract][Full Text] [Related]
9. Analysis of gene mutation associated with tyrosine kinase inhibitor sensitivity of epidermal growth factor receptor in cervical cancer patients.
Wei H; Wang XW; Chen KM; Ling SR; Yi CJ
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6280-6287. PubMed ID: 30338793
[TBL] [Abstract][Full Text] [Related]
10. Detection of Epidermal Growth Factor Receptor (EGFR) Gene Mutation in Formalin Fixed Paraffin Embedded Tissue by Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) in Non-Small Cell Lung Cancer in the Northeastern Region of Thailand.
Saiyaros K; Kritpetcharat P; Pairojkul C; Sithithaworn J
Asian Pac J Cancer Prev; 2019 May; 20(5):1339-1343. PubMed ID: 31127887
[TBL] [Abstract][Full Text] [Related]
11. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
Martinho O; Longatto-Filho A; Lambros MB; Martins A; Pinheiro C; Silva A; Pardal F; Amorim J; Mackay A; Milanezi F; Tamber N; Fenwick K; Ashworth A; Reis-Filho JS; Lopes JM; Reis RM
Br J Cancer; 2009 Sep; 101(6):973-82. PubMed ID: 19707201
[TBL] [Abstract][Full Text] [Related]
12. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
[TBL] [Abstract][Full Text] [Related]
13. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.
Blom T; Roselli A; Häyry V; Tynninen O; Wartiovaara K; Korja M; Nordfors K; Haapasalo H; Nupponen NN
J Neurooncol; 2010 Apr; 97(2):217-24. PubMed ID: 19779861
[TBL] [Abstract][Full Text] [Related]
15. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma.
Ong HS; Gokavarapu S; Tian Z; Li J; Xu Q; Zhang CP; Cao W
J Oral Pathol Med; 2018 Aug; 47(7):652-659. PubMed ID: 29660835
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.
Rodríguez-Antona C; Pallares J; Montero-Conde C; Inglada-Pérez L; Castelblanco E; Landa I; Leskelä S; Leandro-García LJ; López-Jiménez E; Letón R; Cascón A; Lerma E; Martin MC; Carralero MC; Mauricio D; Cigudosa JC; Matias-Guiu X; Robledo M
Endocr Relat Cancer; 2010 Mar; 17(1):7-16. PubMed ID: 19776290
[TBL] [Abstract][Full Text] [Related]
17. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
[TBL] [Abstract][Full Text] [Related]
18. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.
Corless CL; Schroeder A; Griffith D; Town A; McGreevey L; Harrell P; Shiraga S; Bainbridge T; Morich J; Heinrich MC
J Clin Oncol; 2005 Aug; 23(23):5357-64. PubMed ID: 15928335
[TBL] [Abstract][Full Text] [Related]
19. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential.
Kontogianni-Katsarou K; Dimitriadis E; Lariou C; Kairi-Vassilatou E; Pandis N; Kondi-Paphiti A
World J Gastroenterol; 2008 Mar; 14(12):1891-7. PubMed ID: 18350628
[TBL] [Abstract][Full Text] [Related]
20. EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines.
Chakravarty D; Pedraza AM; Cotari J; Liu AH; Punko D; Kokroo A; Huse JT; Altan-Bonnet G; Brennan CW
Sci Rep; 2017 Aug; 7(1):9043. PubMed ID: 28831081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
